| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 08/01/2013 | WO2013112741A1 Apoptosis signal-regulating kinase inhibitor |
| 08/01/2013 | WO2013112323A1 Phenyl methanesulfonamide derivatives useful as mgat - 2 inhibitors |
| 08/01/2013 | WO2013111108A1 5-membered heteroarylcarboxamide derivatives as plasma kallikrein inhibitors |
| 08/01/2013 | WO2013111107A1 Aminopyridine derivatives as plasma kallikrein inhibitors |
| 08/01/2013 | WO2013110622A1 Fluoromethyl-5,6-dihydro-4h-[1,3]oxazines |
| 08/01/2013 | WO2013110433A1 Azaheterocyclic compounds |
| 08/01/2013 | WO2012006474A3 Compounds and methods for inhibiting phosphate transport |
| 08/01/2013 | WO2010120994A3 Ureidoaryl-and carbamoylaryl-morpholino- pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their synthesis |
| 08/01/2013 | US20130197233 Salts of dexlansoprazole and their preparation |
| 08/01/2013 | US20130197232 Process for the preparation of crystalline forms of dexlansoprazole |
| 08/01/2013 | US20130197221 Benzimidazole Derivatives As PI3 Kinase Inhibitors |
| 08/01/2013 | US20130197217 1, 2, 4-triazolone derivative |
| 08/01/2013 | US20130197037 Apoptosis signal-regulating kinase inhibitor |
| 08/01/2013 | US20130197029 Chemical compounds |
| 08/01/2013 | US20130197026 Composition and methods for treating glioblastoma |
| 08/01/2013 | US20130197019 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-ones |
| 08/01/2013 | US20130197013 Cyclopropylamine derivatives useful as lsd1 inhibitors |
| 08/01/2013 | US20130197011 Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament |
| 08/01/2013 | US20130197009 Antagonist for mutant androgen receptor |
| 08/01/2013 | US20130197007 Phenyl-Heteroaryl Derivatives and Methods of Use Thereof |
| 08/01/2013 | US20130196993 N-heteroaryl compounds |
| 08/01/2013 | US20130196991 Substituted indoles, antiviral active component, method for preparation and use thereof |
| 08/01/2013 | US20130196990 Benzimidazole Derivatives As PI3 Kinase Inhibitors |
| 08/01/2013 | US20130196987 Macrocyclic compounds useful as pharmaceuticals |
| 08/01/2013 | US20130196985 Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof |
| 08/01/2013 | US20130196982 Morpholino substituted urea derivatives as mtor inhibitors |
| 08/01/2013 | US20130196975 5-alkynyl-pyridines |
| 08/01/2013 | US20130196974 Compounds for the treatment and prophylaxis of respiratory syncytial virus disease |
| 08/01/2013 | US20130196971 Fatty acid synthase inhibitors |
| 08/01/2013 | US20130196967 Heterocyclic compounds as inhibitors of leukotriene production |
| 08/01/2013 | US20130196952 Heterocyclic derivatives for the treatment of diseases |
| 08/01/2013 | US20130196002 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 08/01/2013 | CA2862030A1 Apoptosis signal-regulating kinase inhibitor |
| 07/31/2013 | EP2620435A1 Phenyl and benzodioxinyl substituted indazole derivatives |
| 07/31/2013 | EP2619185A1 Matrix metalloproteinase inhibitors |
| 07/31/2013 | EP2619181A1 Novel microbiocides |
| 07/31/2013 | EP2619179A1 Matrix metalloproteinase inhibitors |
| 07/31/2013 | EP2619178A1 Substituted benzamide compounds |
| 07/31/2013 | CN103228661A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 07/31/2013 | CN103228645A Microbicidal heterocycles |
| 07/31/2013 | CN103228644A 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of CCR2 |
| 07/31/2013 | CN103228643A Benzazole derivatives as histamine H4 receptor ligands |
| 07/31/2013 | CN103228642A Crystalline forms of hydrochloride salt of (4a-,9a-s)-1-(1h-benzoimidazole-5-carbonyl)-2,3,4,4a,9,9a-hexahydro-1h-indeno[2,1-b]pyridine-6-carbonitrile and their use as HSD 1 inhibitors |
| 07/31/2013 | CN103228634A Matrix metalloproteinase inhibitors |
| 07/31/2013 | CN103228629A Substituted cyclopentyl -azines as CaSR- active compounds |
| 07/31/2013 | CN103228141A Substituted fused pyrimidinones and dihydropyrimidinones |
| 07/31/2013 | CN103224489A Method for enhancing production yield and rate of esomeprazole |
| 07/31/2013 | CN103224488A 杂环化合物或其盐 Heterocyclic compound or a salt thereof |
| 07/31/2013 | CN103224487A Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy |
| 07/31/2013 | CN103224466A Compound with beta-secretase inhibition function, its preparation method and application |
| 07/31/2013 | CN102351843B Synthesis method of 2-methyl piperazine lomefloxacin |
| 07/31/2013 | CN102241669B Preparation method of fasudil hydrochloride |
| 07/31/2013 | CN102026970B Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 07/31/2013 | CN101981008B 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine II receptors |
| 07/31/2013 | CN101921262B Compound used as electrochromic material as well as preparation method and application thereof |
| 07/31/2013 | CN101863883B Piperidone azine compound with activity of resisting leukemia K562 cell proliferation and preparation method thereof |
| 07/31/2013 | CN101679275B Isocarbostyril derivative and its pharmaceutical uses |
| 07/31/2013 | CN101665485B Triazole derivative, and light-emitting element, light-emitting device, and electronic device and lighting device |
| 07/31/2013 | CN101663293B Quinoline-carboxamide derivatives as p2y12 antagonists |
| 07/31/2013 | CN101072758B 喹唑啉衍生物 Quinazoline derivatives |
| 07/30/2013 | US8497379 Method and intermediates for the preparation of 2,2,2-trifluoro-N-(4-fluoro-3-pyridin-4-yl-benzyl)-acetamide hydrochloride |
| 07/30/2013 | US8497288 Hexahydropyrroloimidazolone compounds |
| 07/30/2013 | US8497281 Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline |
| 07/30/2013 | US8497273 Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
| 07/30/2013 | US8497265 Heteroaryloxyheterocyclyl compounds as PDE10 inhibitors |
| 07/30/2013 | CA2659549C Compositions and methods relating to novel compounds and targets thereof |
| 07/30/2013 | CA2611823C Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates |
| 07/30/2013 | CA2599538C N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 07/30/2013 | CA2590811C Heterocycle derivatives as histone deacetylase (hdac) inhibitors |
| 07/30/2013 | CA2561305C Tetrahydro-indazole cannabinoid modulators |
| 07/30/2013 | CA2547410C 1,2,3-triazole amide derivatives as inhibitors of cytokie production |
| 07/30/2013 | CA2531856C Benzimidazole carboxamides as raf kinase inhibitors |
| 07/30/2013 | CA2479764C Hemiasterlin derivatives and uses thereof |
| 07/25/2013 | WO2013109998A1 Metalloenzyme inhibitor compounds |
| 07/25/2013 | WO2013109927A2 Metallodrugs having improved pharmacological properties and methods of manufacture and use thereof |
| 07/25/2013 | WO2013108837A1 Pyrazole derivative with tlr inhibiting properties |
| 07/25/2013 | WO2013108800A1 Substituted phenylazole derivative |
| 07/25/2013 | WO2013108754A1 Pyrazine carboxamide compound |
| 07/25/2013 | WO2013108589A1 Novel compound, material for organic electroluminescent element and organic electroluminescent element |
| 07/25/2013 | WO2013108068A1 Process for the preparation of 2-pyridinylmethylsulfinyl benzimidazoles, their analogs and optically active enantiomers |
| 07/25/2013 | WO2013107820A1 Novel fap inhibitors |
| 07/25/2013 | WO2013107761A1 Substituted triazoles and their use for treatment and/or prevention neurological and psychiatric disorders |
| 07/25/2013 | WO2013107336A1 Therapeutic uses |
| 07/25/2013 | WO2013107285A1 Amino heteroaryl compound, preparation method therefor and use thereof |
| 07/25/2013 | WO2013050987A9 Carbamate/ urea derivatives containing piperidin and piperazin rings as h3 receptor inhibitors |
| 07/25/2013 | US20130190371 Fungicide Active Substance Combinations |
| 07/25/2013 | US20130190363 Therapeutic agent for neurological diseases |
| 07/25/2013 | US20130190362 Arthropodicidal anthranilamides |
| 07/25/2013 | US20130190355 Dual inhibitors of farnesyltransferase and geranylgeranyltransferase i |
| 07/25/2013 | US20130190350 Mediators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto |
| 07/25/2013 | US20130190339 Pro-Neurogenic Compounds |
| 07/25/2013 | US20130190330 Bisaryl-bonded aryltriazolones and use thereof |
| 07/25/2013 | US20130190325 Compounds for treating proliferative disorders |
| 07/25/2013 | US20130190320 Heterocyclic compounds and uses as anticancer agents |
| 07/25/2013 | US20130190313 Arthropodicidal anthranilamides |
| 07/25/2013 | US20130190311 Pyridazinone derivatives |
| 07/25/2013 | US20130190309 Phthalazinone and related analogs as sirtuin modulators |
| 07/25/2013 | US20130190302 Modulators of amyloid beta |
| 07/25/2013 | US20130190300 Compositions and methods for inhibiting the proliferation of cells |
| 07/25/2013 | US20130190298 Substituted pyridazine carboxamide compounds |